This is an old revision of this page, as edited by BogBot (talk | contribs) at 01:45, 21 September 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:45, 21 September 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Trimethoprim/polymyxin B" – news · newspapers · books · scholar · JSTOR (February 2011) (Learn how and when to remove this message) |
Combination of | |
---|---|
Trimethoprim | Nucleic acid inhibitor antibiotic |
Polymyxin | Cell envelope antibiotic |
Clinical data | |
Routes of administration | Eye drops |
ATC code | |
Identifiers | |
PubChem CID | |
CompTox Dashboard (EPA) | |
(verify) |
The drug combination trimethoprim/polymyxin (INNs, trade name Polytrim) is an antimicrobial solution for topical ophthalmic use in the treatment of acute bacterial conjunctivitis and blepharoconjunctivitis.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |